Variables | Deceased n (%) | No deceased n (%) | p |
Complications |
|
|
|
· Liquid ascite infection | 5 (5.75) | 7 (5.88) | 1.000 |
· HCC | 41 (47.13) | 34 (28.57) | 0.010 |
· Gastrointestinal bleeding | 20 (22.99) | 22 (18.49) | 0.537 |
· Hepatic encephalopathy | 53 (60.92) | 18 (15.13) | <0.001 |
· Hepatorenal syndrome | 4 (4.60) | 0 (0.00) | 0.031 |
Pronostic score |
|
|
|
· Child-Pugh A | 0 (0.00) | 9 (7.83) | 0.027 |
· Child-Pugh B | 26 (32.50) | 95 (82.61) | 0.001 |
· Child-Pugh C | 54 (67.50) | 11 (9.57) | <0.001 |
Treatment |
|
|
|
· Fluoroquinolone | 12 (13.79) | 25 (21.01) | 0.25 |
· Tramadol | 69 (79.31) | 68 (57.14) | 0.001 |
· Furosemide | 8 (9.20) | 12 (10.08) | 1.000 |
· Spironolactone | 5 (5.75) | 31 (26.05) | <0.001 |
· Lactulose | 72 (82.76) | 73 (61.34) | 0.002 |
· Betablockers | 9 (10.34) | 31 (26.05) | 0.008 |
· Blood transfusion | 19 (21.84) | 30 (25.21) | 0.69 |
· Number paracentesis ≥ 2 | 22 (25.29) | 54 (45.38) | 0.005 |